{
    "2018-01-30": [
        [
            {
                "time": "2018-01-30",
                "original_text": "Sanofi on a Buyout Spree This Month, to Buy Ablynx for $4.8B",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Buyout",
                        "Ablynx",
                        "4.8B"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-30",
                "original_text": "Can Merck (MRK) Deliver a Positive Surprise in Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Merck",
                        "Q4",
                        "Earnings",
                        "Positive",
                        "Surprise"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-30",
                "original_text": "Why Novo Nordisk (NVO) Might Surprise This Earnings Season",
                "features": {
                    "keywords": [
                        "Novo",
                        "Nordisk",
                        "Earnings",
                        "Season",
                        "Surprise"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-30",
                "original_text": "Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Novo",
                        "Ablynx",
                        "4.8",
                        "billion",
                        "biotech",
                        "M&A"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}